aluminum phosphate: Clinical Trials

2 trials of aluminum phosphate, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 unknown. 2 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 12Completed 1, Unknown 1

Follow aluminum phosphate: new trials by email Literature Review of aluminum phosphate trials Research Report on aluminum phosphate

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Phase I Safty and Immunogenicity Study of SCT1000 in Healthy Women Aged 18 to 45 Years
SCT1000, Gardasil®9, placebo - HPV Infection Vaccine Safety SCT1000
Phase 1UnknownSinocelltech Ltd.2402021-07-022021-09-17
Safety and Immunogenicity of EBA-175 RII-NG Malaria Vaccine Administered Intramuscularly
Aluminum Phosphate, Placebo, EBA-175 RII-NG Malaria Vaccine - Plasmodium Falciparum Malaria
Phase 1CompletedNational Institute of Allergy and Infectious Diseases (NIAID)802006-05-012013-04-12

Conditions studied

Malaria (1)  ·  Malaria, Falciparum (1)

Sponsors

National Institute of Allergy and Infectious Diseases (NIAID) (1)  ·  Sinocelltech Ltd. (1)

Countries

China (1)  ·  United States (1)

Results publications

PMID 16753240, PMID 21142263, PMID 27503625